0001391045-15-000003.txt : 20150504 0001391045-15-000003.hdr.sgml : 20150504 20150504160450 ACCESSION NUMBER: 0001391045-15-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150430 FILED AS OF DATE: 20150504 DATE AS OF CHANGE: 20150504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NephroGenex, Inc. CENTRAL INDEX KEY: 0001338095 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3200 BEECHLEAF COURT STREET 2: SUITE 900 CITY: RALEIGH STATE: NC ZIP: 27604 BUSINESS PHONE: (609) 986-1780 MAIL ADDRESS: STREET 1: 3200 BEECHLEAF COURT STREET 2: SUITE 900 CITY: RALEIGH STATE: NC ZIP: 27604 FORMER COMPANY: FORMER CONFORMED NAME: NephroGenex Inc DATE OF NAME CHANGE: 20050907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Legault Pierre CENTRAL INDEX KEY: 0001391045 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36303 FILM NUMBER: 15828436 MAIL ADDRESS: STREET 1: P.O. BOX 1028 STREET 2: C/O STONE MANAGEMENT LLC CITY: BERWYNE STATE: PA ZIP: 19312 4 1 wf-form4_143076988027516.xml FORM 4 X0306 4 2015-04-30 0 0001338095 NephroGenex, Inc. NRX 0001391045 Legault Pierre C/O NEPHROGENEX, INC. 3200 BEECHLEAF COURT, SUITE 900 RALEIGH NC 27604 1 1 0 0 Chief Executive Officer Options to Purchase Common Stock 7.31 2015-04-30 4 A 0 50000 0 A 2016-04-30 2025-04-30 Common Stock 50000.0 50000 D 25% of the shares underlying the options will vest on April 30, 2016 and the remainder of the shares underlying the options will vest on a pro rata monthly basis for a three-year period following April 30, 2016. /s/ Pierre Legault, as attorney in-fact 2015-05-04